世界中医药2017，Vol.12Issue(6)：1368-1370,1374,4.DOI:10.3969/j.issn.1673-7202.2017.06.039
基于健脾疏肝法观察超声药物透入治疗非酒精性脂肪性肝病30例
Observation of 30 Cases of Non-alcoholic Fatty Liver Disease Treated by Ultrasound Drug Penetration
摘要
Abstract
Objective:To observe the efficacy of ultrasound drug penetration in the treatment of NAFLD.Methods:A total of 30 patients were randomly divided into two groups.The treatment group were treated by ultrasound drug penetration of spleen-tonifying and liver-soothing medicine and the control group by ultrasound ion penetration.The treatment lasted for three months.Then,three-months' follow-ups were performed for each patient.The monitored indexes included BMI,serum transaminase,liver/spleen CT ratio and clinical symptoms.Results:Both treatments in the two groups effectively improved the serum ALT,AST levels,reduced the patient's liver/spleen CT value,improved the patient's BMI,and relieved the clinical symptoms including liver pain,abdominal distention,and fatigue (P ＜0.001).Condusion:The formula in the treatment of NAFLD has a good effect with the long-term efficacy reflected in diet and sports.关键词
超声药物透入/健脾疏肝法/非酒精性脂肪性肝病Key words
Ultrasound drug penetration/Spleen-tonifying and liver-soothing method/Non-alcoholic fatty liver disease分类
医药卫生引用本文复制引用
苏冬梅,李树斌,李军祥,李影华..基于健脾疏肝法观察超声药物透入治疗非酒精性脂肪性肝病30例[J].世界中医药,2017,12(6):1368-1370,1374,4.基金项目
北京市大兴区科技发展计划项目(编号:15048-1)——基于健脾疏肝法探讨超声离子透入对脂肪肝的疗效 （编号:15048-1）
